These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 19943923)

  • 1. The TGF-beta1 dynamics during radiation therapy and its correlation to symptomatic radiation pneumonitis in lung cancer patients.
    Kim JY; Kim YS; Kim YK; Park HJ; Kim SJ; Kang JH; Wang YP; Jang HS; Lee SN; Yoon SC
    Radiat Oncol; 2009 Nov; 4():59. PubMed ID: 19943923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variations of circulating endothelial progenitor cells and transforming growth factor-beta-1 (TGF-β1) during thoracic radiotherapy are predictive for radiation pneumonitis.
    Liu Y; Xia T; Zhang W; Zhong Y; Zhang L; Wang X; Yu H
    Radiat Oncol; 2013 Jul; 8():189. PubMed ID: 23885707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of plasma transforming growth factor-beta levels in radiotherapy for non-small-cell lung cancer.
    De Jaeger K; Seppenwoolde Y; Kampinga HH; Boersma LJ; Belderbos JS; Lebesque JV
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1378-87. PubMed ID: 15050313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine plasma levels: reliable predictors for radiation pneumonitis?
    Rübe CE; Palm J; Erren M; Fleckenstein J; König J; Remberger K; Rübe C
    PLoS One; 2008 Aug; 3(8):e2898. PubMed ID: 18682839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining physical and biologic parameters to predict radiation-induced lung toxicity in patients with non-small-cell lung cancer treated with definitive radiation therapy.
    Stenmark MH; Cai XW; Shedden K; Hayman JA; Yuan S; Ritter T; Ten Haken RK; Lawrence TS; Kong FM
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):e217-22. PubMed ID: 22935395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma Levels of IL-8 and TGF-β1 Predict Radiation-Induced Lung Toxicity in Non-Small Cell Lung Cancer: A Validation Study.
    Wang S; Campbell J; Stenmark MH; Zhao J; Stanton P; Matuszak MM; Ten Haken RK; Kong FS
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(3):615-621. PubMed ID: 28581403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF-beta1 in serum and induced sputum for predicting radiation pneumonitis in patients with non-small cell lung cancer after radiotherapy.
    Wang J; Qiao XY; Lu FH; Zhou ZG; Song YZ; Huo JJ; Liu X
    Chin J Cancer; 2010 Mar; 29(3):325-9. PubMed ID: 20193119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early variations of circulating interleukin-6 and interleukin-10 levels during thoracic radiotherapy are predictive for radiation pneumonitis.
    Arpin D; Perol D; Blay JY; Falchero L; Claude L; Vuillermoz-Blas S; Martel-Lafay I; Ginestet C; Alberti L; Nosov D; Etienne-Mastroianni B; Cottin V; Perol M; Guerin JC; Cordier JF; Carrie C
    J Clin Oncol; 2005 Dec; 23(34):8748-56. PubMed ID: 16314635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does transforming growth factor-beta1 predict for radiation-induced pneumonitis in patients treated for lung cancer?
    Evans ES; Kocak Z; Zhou SM; Kahn DA; Huang H; Hollis DR; Light KL; Anscher MS; Marks LB
    Cytokine; 2006 Aug; 35(3-4):186-92. PubMed ID: 16979900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlation study of physical and biologic parameters to acute radiation pneumonitis].
    Zhao YH; Li ZP; Chen XM; Liu XJ; Wu WC; Xu Y; Li P; Zhang JT; Zeng H
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):796-800. PubMed ID: 19024317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study on the controlling effect of Shenqi Fuzheng injection on plasma cytokine network in patients with thoracic tumor undergoing radiotherapy].
    Liu L; Ding Q; Dai XF
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Dec; 27(12):1082-5. PubMed ID: 18198640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive factors of late radiation fibrosis: a prospective study in non-small cell lung cancer.
    Mazeron R; Etienne-Mastroianni B; Pérol D; Arpin D; Vincent M; Falchero L; Martel-Lafay I; Carrie C; Claude L
    Int J Radiat Oncol Biol Phys; 2010 May; 77(1):38-43. PubMed ID: 20171801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in plasma transforming growth factor beta during radiotherapy and the risk of symptomatic radiation-induced pneumonitis.
    Anscher MS; Kong FM; Marks LB; Bentel GC; Jirtle RL
    Int J Radiat Oncol Biol Phys; 1997 Jan; 37(2):253-8. PubMed ID: 9069294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical value of serum Ape1/Ref-1 combined with TGF-β1 monitoring in predicting the occurrence of radiation pneumonitis (RP) in non-small cell lung cancer patients.
    Zhang Y; You H; Duan J; Gao Y
    Ann Palliat Med; 2021 Mar; 10(3):3328-3335. PubMed ID: 33849117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation pneumonitis and early circulatory cytokine markers.
    Chen Y; Williams J; Ding I; Hernady E; Liu W; Smudzin T; Finkelstein JN; Rubin P; Okunieff P
    Semin Radiat Oncol; 2002 Jan; 12(1 Suppl 1):26-33. PubMed ID: 11917281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective Exploratory Study of the Relationship Between Radiation Pneumonitis and TGF-β1 in Exhaled Breath Condensate.
    Takahashi S; Anada M; Kinoshita T; Nishide T; Shibata T
    In Vivo; 2022; 36(3):1485-1490. PubMed ID: 35478101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The predictive role of plasma TGF-beta1 during radiation therapy for radiation-induced lung toxicity deserves further study in patients with non-small cell lung cancer.
    Zhao L; Sheldon K; Chen M; Yin MS; Hayman JA; Kalemkerian GP; Arenberg D; Lyons SE; Curtis JL; Davis M; Cease KB; Brenner D; Anscher MS; Lawrence TS; Kong FM
    Lung Cancer; 2008 Feb; 59(2):232-9. PubMed ID: 17905467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-beta plasma dynamics and post-irradiation lung injury in lung cancer patients.
    Novakova-Jiresova A; Van Gameren MM; Coppes RP; Kampinga HH; Groen HJ
    Radiother Oncol; 2004 May; 71(2):183-9. PubMed ID: 15110452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutrophil-lymphocyte ratio and a dosimetric factor for predicting symptomatic radiation pneumonitis in non-small-cell lung cancer patients treated with concurrent chemoradiotherapy.
    Lee YH; Choi HS; Jeong H; Kang KM; Song JH; Lee WS; Lee GW; Song HN; Kim HG; Kang MH; Rhee DY; Jeong BK
    Clin Respir J; 2018 Mar; 12(3):1264-1273. PubMed ID: 28618180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor-beta-1 is a serum biomarker of radiation-induced pneumonitis in esophageal cancer patients treated with thoracic radiotherapy: preliminary results of a prospective study.
    Li J; Mu S; Mu L; Zhang X; Pang R; Gao S
    Onco Targets Ther; 2015; 8():1129-36. PubMed ID: 26056477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.